NOVAVAX INC
10-K
February 26, 2026
Key Highlights
- Strategic partnership with Sanofi expected to generate $1 billion in 2025 revenu...
- Pivoting to a 'capital-light' model, focusing on core strengths: recombinant pro...
- Strong pipeline potential, including combination COVID-19/flu vaccine, and furth...
Read Analysis
🤖 AI Generated